Research Paper Volume 15, Issue 4 pp 1210—1227
Inhibition of apoptosis through AKT-mTOR pathway in ovarian cancer and renal cancer
Figure 3. WGCNA analysis. (A) relationship between module and clinical manifestations of ovarian cancer; (B) Module Membership in darkolivegreen4 module: p = 9.1e-6, r = 0.70; (C) Module Membership in black module: p = 1.6e-37, r = 0.52; (D) Module Membership in brown2 module: p = 5.7e-228, r = 0.63; (E) Module Membership in darkmagenta module: p = 0.0e + 0, r = 0.65; (F) Membership in coral1 module: p = 5.5e-6, r = 0.64; (G) Membership in salmon4 module: p = 9.7e-15, r = 0.57.